Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment

Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment

Hepatic impairment, characterized by decreased liver function, does not uniformly mandate adjustments in drug dosage. Whether dosage modifications are necessary depends on various factors related to the drug's metabolism and elimination pathways. If a drug is primarily excreted via the kidneys and bypasses significant hepatic processing, if it undergoes minimal metabolic transformation in the liver, or if it is volatile and primarily expelled through the lungs, dose adjustments may not be...

Disorders of the Male Reproductive System

Disorders of the Male Reproductive System

Men's health issues are increasingly recognized as significant, with several conditions posing common threats. Among these, testicular cancer is especially prevalent in younger men, particularly those aged 20 to 35 years. The disease often manifests as a painless mass in the testicles, sometimes accompanied by a sensation of heaviness or a dull ache.
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra. Symptoms...

Drug Dosing: Geriatric Patients

Drug Dosing: Geriatric Patients

Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...

Pharmacodynamics in Geriatric Patients: Effects of Age

Pharmacodynamics in Geriatric Patients: Effects of Age

Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption

As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution

Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are not...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Associations of urinary incontinence, absorbent product use, and confidence gained from absorbent product use with perceived ageism in later adulthood.

The Gerontologist·2026

Same author

Bivalent RSVpreF effectiveness against RSV-associated hospital or emergency department care over two seasons: a retrospective test-negative case control study.

Lancet regional health. Americas·2026

Same author

Air pollution and respiratory outcomes in COPD above and below current environmental protection agency standards.

Environmental epidemiology (Philadelphia, Pa.)·2026

Same author

Towards early detection of pancreatic cancer: The current status of cohort studies by the Diabetes-Pancreatic Ductal AdenoCarcinoma Working Group.

Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.]·2026

Same author

Polygenic scores for risk of pancreatic ductal adenocarcinoma: evaluation of novel and published models.

NPJ precision oncology·2026

Same author

BNT162b2 2024-2025 Vaccine Effectiveness Against COVID-19 in Children Aged 6 Months-17 Years.

Journal of the Pediatric Infectious Diseases Society·2026

Search research articles

Related Experiment Video

Updated: May 27, 2026

Treatment Model for Young Patients with Psychogenic Erectile Dysfunction and Resultant Infertility

Treatment Model for Young Patients with Psychogenic Erectile Dysfunction and Resultant Infertility

Published on: May 30, 2025

Population-based study of erectile dysfunction and polypharmacy.

Diana C Londoño¹, Jeff M Slezak, Virginia P Quinn

¹Department of Urology, Kaiser Permanente Los Angeles Medical Center, Los Angeles, CA, USA.

BJU International

|November 17, 2011

Summary

The number of medications taken is linked to increased erectile dysfunction (ED) severity in men. This association persists even when accounting for common health conditions, suggesting medication review may improve ED outcomes.

Related Experiment Videos

Last Updated: May 27, 2026

Treatment Model for Young Patients with Psychogenic Erectile Dysfunction and Resultant Infertility

Treatment Model for Young Patients with Psychogenic Erectile Dysfunction and Resultant Infertility

Published on: May 30, 2025

Area of Science:

Urology
Public Health
Pharmacology

Background:

Erectile dysfunction (ED) is a common condition influenced by various medical factors including diabetes, hypertension, and high cholesterol.
Previous research has established links between specific health conditions and ED at both molecular and population levels.

Purpose of the Study:

To investigate the association between erectile dysfunction (ED) and the use of multiple medications (polypharmacy).
To analyze this relationship within a large, diverse cohort of men from the California Men's Health Study (CMHS).

Main Methods:

A cohort of 37,712 men aged 45-69 from Kaiser Permanente Southern California (KPSC) was studied.
Erectile dysfunction (ED) and comorbidities were assessed via questionnaires.
Medication use was determined through electronic pharmacy records and questionnaires for the year preceding enrollment.

Main Results:

29% of participants reported moderate to severe ED.
A significant dose-response relationship was observed: higher medication counts correlated with increased ED prevalence.
Men taking 10 or more medications had more than double the odds of ED (OR=2.32) after adjusting for comorbidities and other factors.

Conclusions:

The number of medications a man takes is independently associated with worse erectile dysfunction (ED).
These findings highlight the potential impact of polypharmacy on ED, independent of underlying health conditions.
Results can aid clinicians in diagnosing ED and optimizing medication regimens to improve patient quality of life.